BTL Files Patent Infringement Lawsuit Against Allergan and Zimmer Related to Emsculpt

January 2, 2020

BTL Aesthetics’ U.S. affiliate has filed a lawsuit against Allergan plc, Ireland, and its affiliates, and Zimmer MedizinSysteme GmbH, Germany, and its affiliate, in the U.S. Federal District Court for the District of Delaware.
The lawsuit asserts that the CoolTone device, manufactured by Zimmer for Allergan, infringes on BTL’s U.S. patents. The lawsuit further asserts that Allergan’s CoolSculpting, when used before, or after the CoolTone therapy, infringes on BTL’s U.S. patent for the therapeutic application of the two technologies.Read more at Modern Aesthetics >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • 10 Marketing Truths Every Aesthetic Practice Needs to Hear Right Now
    • AI, FDA, PDGF: The Talk of MSS
    • Radiologists Warn that Décolletage Filler May Interfere with Breast Cancer Screening
    • The Beauty Health Company (SKIN) Rebrands to SkinHealth Systems
    • Amazon Launches GLP-1 Weight Loss Program with One Medical